Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Blinatumomab in Children with Relapsed or Refractory B-Precursor Acute Lymphoblastic Leukemia (R/R-ALL): Final Results of 110 Patients Treated in an Expanded Access Study (RIALTO)

Franco Locatelli, MD PhD, Gerhard Zugmaier, Noemi Mergen, MD, Peter Bader, MD, Sima Jeha, MD, Paul-Gerhardt Schlegel, Jean-Pierre Bourquin, MD PhD, Rupert Handgretinger, MD, Benoit Brethon, MD, Claudia Rössig, William Kormany, MD, Puneeth Viswagnachar, Christiane Chen-Santel

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-141336

Published: 2020

Journal Articles

Clinical Implications of Minimal Residual Disease Detection in Infants with KMT2A -Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol

Blood (2020) 136 (Supplement 1): 41–42.

https://doi.org/10.1182/blood-2020-134303

Published: 2020

Journal Articles

Blinatumomab in Pediatric Patients with Relapsed/Refractory B-Cell Precursor and Molecularly Resistant Acute Lymphoblastic Leukemia (R/R ALL): Updated Analysis of 110 Patients Treated in an Expanded Access Study (RIALTO)

Franco Locatelli, MD, Gerhard Zugmaier, Peter Bader, MD, Sima Jeha, MD, Paul-Gerhardt Schlegel, Jean-Pierre Bourquin, MD PhD, Rupert Handgretinger, MD, Benoit Brethon, MD, Claudia Rossig, Christiane Chen-Santel

Blood (2019) 134 (Supplement_1): 1294.

https://doi.org/10.1182/blood-2019-121615

Published: 2019

Journal Articles

Azacitidine in Pediatric Hematologic Myeloid Malignancies: A Retrospective Study

Emilie Saucier, Florence Rabian, MD, Hélène Boutroux, MD, Marion Strullu, MD, Karine Morand, MD, Florian Chevillon, MD, Benoit Brethon, MD, Nicolas Boissel, MD PhD, Guy Leverger, MD, André Baruchel, MD

Blood (2019) 134 (Supplement_1): 5130.

https://doi.org/10.1182/blood-2019-131062

Published: 2019

Journal Articles

A Phase I Study of Single-Agent Inotuzumab Ozogamicin in Pediatric CD22-Positive Relapsed/Refractory Acute Lymphoblastic Leukemia: Preliminary Results of the ITCC-059 Study

Blood (2019) 134 (Supplement_1): 2629.

https://doi.org/10.1182/blood-2019-122411

Published: 2019

Journal Articles

Oncogenetic Risk Classification Based on NOTCH1/FBXW7/RAS/PTEN Mutation Profiles Improves Outcome Prediction in Pediatric T-Cell Acute Lymphoblastic Leukemia, Treated According the Fralle 2000 T Guidelines

Arnaud Petit, MD PhD, Amélie Trinquand, MD, Sylvie Chevret, MD PhD, Paola Fabiola Ballerini, MD PhD, Jean-Michel Cayuela, MD, Nathalie Grardel, MD, Aurore Touzart, MD, Benoit Brethon, MD, Hélène Lapillonne, MD PhD, Pascal Chastagner, MD, Claire Berger, MD, Gerard Michel, MD, Claude Preudhomme, MD PhD, Jean Soulier, MD PhD, Judith Landman-Parker, MD, Guy Leverger, MD, Elizabeth Macintyre, MD PhD, Andre Baruchel, MD PhD, Vahid Asnafi, MD PhD

Blood (2016) 128 (22): 1083.

https://doi.org/10.1182/blood.V128.22.1083.1083

Published: 2016

Journal Articles

Safety and Efficacy of Blinatumomab Used in Children with B-Precursor Acute Lymphoblastic Leukemia (ALL) Treated in French Hematological Centers

Anne-Flore Derache, MD, Fanny Rialland, MD, Gerard Michel, MD, Yves Perel, MD, Virginie Gandemer, MD PhD, Pascale Blouin, MD, Odile Minckes, MD, Arnaud Petit, MD PhD, Andre Baruchel, MD PhD, Benoit Brethon, MD

Blood (2016) 128 (22): 5190.

https://doi.org/10.1182/blood.V128.22.5190.5190

Published: 2016

Journal Articles

Late Effects in Survivors of Infantile Acute Leukemia Are Less Severe Than Expected: A Study of the L.E.a Program

Blood (2016) 128 (22): 3571.

https://doi.org/10.1182/blood.V128.22.3571.3571

Published: 2016

Journal Articles

Immunophenotypic Profiling of Childhood B-Cell Precursor Acute Lymphoblastic Helps Identifying Genetic Subtypes, Including Recently Identified Ones

Elodie Lainey, PharmD/PhD, Aurelie Caye-Eude, PharmD, Lucile Broseus, Emmanuelle Clappier, PharmD, PhD, Wendy Cuccuini, MD PhD, Cristina Leschi, PharmD, Odile Fenneteau, PharmD, Jimmy Mullaert, Amandine Chaye, Ahlene Emam, Benoit Brethon, MD, Thierry Leblanc, MD, Andre Baruchel, MD, Helene Cave, PharmD, PhD

Blood (2016) 128 (22): 2910.

https://doi.org/10.1182/blood.V128.22.2910.2910

Published: 2016

Journal Articles

A Phase 1/2, Open-Label, Dose-Escalation Study of Midostaurin in Pediatric Patients (Pts) with Relapsed or Refractory (R/R) Acute Leukemia: Final Results of Study ITCC-024 (CPKC412A2114)

C. Michel Zwaan, MD PhD, Stefan Söderhäll, MD PhD, Benoit Brethon, MD, Matteo Luciani, MD, Carmelo Rizzari, MD, David Sternberg, MD PhD, Emmanuelle Besse, Catherine Dutreix, MD, Franca Fagioli, MD, Phoenix Ho, MD, Carlo Dufour, MD, Rob Pieters, MD PhD

Blood (2015) 126 (23): 2564.

https://doi.org/10.1182/blood.V126.23.2564.2564

Published: 2015

Journal Articles

Clofarabine in Combination with High-Dose Cytarabine and Liposomal Daunorubicin in Pediatric AML: Results of a Phase 1B Combination Study By the ITCC Consortium

Christian M. Zwaan, MD PhD, Michael Dworzak, MD PhD, Thomas Klingebiel, MD, Claudia Rössig, MD, Guy Leverger, MD, Jan Stary, Evelina S. de Bont, MDPhD, Satianand Ramnarain, MSc, Yves Bertrand, MD, Benoit Brethon, MD, Brigitte Strahm, MD, Gertjan J. Kaspers, MD PhD, Dirk Reinhardt, MD PhD

Blood (2014) 124 (21): 989.

https://doi.org/10.1182/blood.V124.21.989.989

Published: 2014

Journal Articles

Nelarabine Alone or in Combination in High Risk Childhood / Adolescent and Young Adults (AYA) T- Cell Acute Lymphoblastic Leukemia

Benoit Brethon, MD, Laetitia Morel, MD, Arnaud Petit, MD PhD, Etienne Lengliné, MD, Aurelie Cuinet, MD, Genevieve Vaudre, Thierry Leblanc, MD, Marie-Dominique Tabone, MD, Guy Leverger, MD, Nicolas Boissel, MD PhD, André Baruchel, MD

Blood (2014) 124 (21): 3723.

https://doi.org/10.1182/blood.V124.21.3723.3723

Published: 2014

Journal Articles

Daunorubicin or Not During the Induction Treatment of Childhood Standard-Risk B-Cell Precursor Acute Lymphoblastic Leukemia (SR-BCP-ALL): The Randomized Fralle 2000-A Protocol

Blood (2012) 120 (21): 135.

https://doi.org/10.1182/blood.V120.21.135.135

Published: 2012

Journal Articles

Safety of Clofarabine with Multiagent Chemotherapy in Childhood High Risk Relapse of Acute Lymphoblastic Leukemia (Vandevol study of the French SFCE Acute Leukemia Committee).

Brigitte Nelken, MD, Guy Leverger, MD, Claire Galambrun, MD, Genevieve Plat, Claudine Schmitt, MD, Caroline Thomas, M.D., Cécile Vérité, MD, Benoit Brethon, MD, Virginie Gandemer, Yves Bertrand, André Baruchel, Pierre Rohrlich

Blood (2012) 120 (21): 2570.

https://doi.org/10.1182/blood.V120.21.2570.2570

Published: 2012

Journal Articles

Sodium Gluconate Containing Parenteral Nutrition Solution as a Cause of False Positive Aspergillus Galactomannan Assay in Paediatric Patients with Hematological Malignancies.

Patricia Ribaud, MD, Annie Sulahian, PhD, Sophie Touratier, PhD, Benoit Brethon, MD, Regis Peffault de Latour, MD, Gerard Socie, MD, PhD, Jean Menotti, PhD, Francis Derouin, MD, PhD

Blood (2007) 110 (11): 4958.

https://doi.org/10.1182/blood.V110.11.4958.4958

Published: 2007

Journal Articles

The Challenge of Diagnosing Fanconi Anemia in Patients with Bone Marrow Failure (BMF): A Study in 82 BMF Patients.

Fernando O. Pinto, MD, Thierry Leblanc, MD, Gwenaelle Le Roux, Jerome Larghero, PhD, Bruno Cassinat, MD, PhD, Moema Santos, MD, Benoit Brethon, MD, Caroline Oudot, MD, Odile Maarek, MD, Gerard Socie, MD, PhD, Andre Baruchel, MD, Eliane Gluckman, MD, Jean Soulier, MD, PhD

Blood (2006) 108 (11): 991.

https://doi.org/10.1182/blood.V108.11.991.991

Published: 2006

Journal Articles

Efficacy of the Combination of Gemtuzumab-Ozogamicin (Mylotarg(R)) and Cytarabine (GOCYT) in Childhood Myeloid Leukemia: A Compassionate Use Based Review in France.

Benoit Brethon, MD, Karima Yakouben, MD, Caroline Oudot, MD, Patrick Boutard, MD, Benedicte Bruno, MD, Cecile Jerome, MD, Brigitte Nelken, MD, Lionel de Lumley, MD, Yves Bertrand, MD, Jean-Hugues Dalle, MD,PhD, Thierry Leblanc, MD, Andre Baruchel, MD

Blood (2006) 108 (11): 2015.

https://doi.org/10.1182/blood.V108.11.2015.2015

Published: 2006

NARROW

Blinatumomab in Children with Relapsed or Refractory B-Precursor Acute Lymphoblastic Leukemia (R/R-ALL): Final Results of 110 Patients Treated in an Expanded Access Study (RIALTO)

Clinical Implications of Minimal Residual Disease Detection in Infants with KMT2A -Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol

Blinatumomab in Pediatric Patients with Relapsed/Refractory B-Cell Precursor and Molecularly Resistant Acute Lymphoblastic Leukemia (R/R ALL): Updated Analysis of 110 Patients Treated in an Expanded Access Study (RIALTO)

Azacitidine in Pediatric Hematologic Myeloid Malignancies: A Retrospective Study

A Phase I Study of Single-Agent Inotuzumab Ozogamicin in Pediatric CD22-Positive Relapsed/Refractory Acute Lymphoblastic Leukemia: Preliminary Results of the ITCC-059 Study

Oncogenetic Risk Classification Based on NOTCH1/FBXW7/RAS/PTEN Mutation Profiles Improves Outcome Prediction in Pediatric T-Cell Acute Lymphoblastic Leukemia, Treated According the Fralle 2000 T Guidelines

Safety and Efficacy of Blinatumomab Used in Children with B-Precursor Acute Lymphoblastic Leukemia (ALL) Treated in French Hematological Centers

Late Effects in Survivors of Infantile Acute Leukemia Are Less Severe Than Expected: A Study of the L.E.a Program

Immunophenotypic Profiling of Childhood B-Cell Precursor Acute Lymphoblastic Helps Identifying Genetic Subtypes, Including Recently Identified Ones

A Phase 1/2, Open-Label, Dose-Escalation Study of Midostaurin in Pediatric Patients (Pts) with Relapsed or Refractory (R/R) Acute Leukemia: Final Results of Study ITCC-024 (CPKC412A2114)

Clofarabine in Combination with High-Dose Cytarabine and Liposomal Daunorubicin in Pediatric AML: Results of a Phase 1B Combination Study By the ITCC Consortium

Nelarabine Alone or in Combination in High Risk Childhood / Adolescent and Young Adults (AYA) T- Cell Acute Lymphoblastic Leukemia

Daunorubicin or Not During the Induction Treatment of Childhood Standard-Risk B-Cell Precursor Acute Lymphoblastic Leukemia (SR-BCP-ALL): The Randomized Fralle 2000-A Protocol

Safety of Clofarabine with Multiagent Chemotherapy in Childhood High Risk Relapse of Acute Lymphoblastic Leukemia (Vandevol study of the French SFCE Acute Leukemia Committee).

Sodium Gluconate Containing Parenteral Nutrition Solution as a Cause of False Positive Aspergillus Galactomannan Assay in Paediatric Patients with Hematological Malignancies.

The Challenge of Diagnosing Fanconi Anemia in Patients with Bone Marrow Failure (BMF): A Study in 82 BMF Patients.

Efficacy of the Combination of Gemtuzumab-Ozogamicin (Mylotarg(R)) and Cytarabine (GOCYT) in Childhood Myeloid Leukemia: A Compassionate Use Based Review in France.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only